Literature DB >> 25716073

Prognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia.

Tapan Kadia1, Hagop Kantarjian1, Guillermo Garcia-Manero1, Gautam Borthakur1, Xuemei Wang2, Keyur Patel3, Elias Jabbour1, Mark Brandt1, Naval Daver1, Naveen Pemmaraju1, Sherry Pierce1, Jorge Cortes1, Farhad Ravandi4.   

Abstract

Entities:  

Keywords:  acute myeloid leukaemia; cytogenetics of leukaemia; prognostic factors

Mesh：

Substances：

Year:  2015        PMID： 25716073      PMCID： PMC4977576          DOI： 10.1111/bjh.13319

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.

Authors:  Christoph Röllig; Martin Bornhäuser; Christian Thiede; Franziska Taube; Michael Kramer; Brigitte Mohr; Walter Aulitzky; Heinrich Bodenstein; Hans-Joachim Tischler; Reingard Stuhlmann; Ulrich Schuler; Friedrich Stölzel; Malte von Bonin; Hannes Wandt; Kerstin Schäfer-Eckart; Markus Schaich; Gerhard Ehninger
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

3.  Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Authors:  Richard F Schlenk; Konstanze Döhner; Jürgen Krauter; Stefan Fröhling; Andrea Corbacioglu; Lars Bullinger; Marianne Habdank; Daniela Späth; Michael Morgan; Axel Benner; Brigitte Schlegelberger; Gerhard Heil; Arnold Ganser; Hartmut Döhner
Journal:  N Engl J Med       Date:  2008-05-01       Impact factor: 91.245

Review 4.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

5.  Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

Authors:  Krzysztof Mrózek; Guido Marcucci; Deedra Nicolet; Kati S Maharry; Heiko Becker; Susan P Whitman; Klaus H Metzeler; Sebastian Schwind; Yue-Zhong Wu; Jessica Kohlschmidt; Mark J Pettenati; Nyla A Heerema; AnneMarie W Block; Shivanand R Patil; Maria R Baer; Jonathan E Kolitz; Joseph O Moore; Andrew J Carroll; Richard M Stone; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544
  5 in total
  5 in total

Review 1.  Frontline treatment of acute myeloid leukemia in adults.

Authors:  Gevorg Tamamyan; Tapan Kadia; Farhad Ravandi; Gautam Borthakur; Jorge Cortes; Elias Jabbour; Naval Daver; Maro Ohanian; Hagop Kantarjian; Marina Konopleva
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-11       Impact factor: 6.312

2.  Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.

Authors:  Ana Espirito Santo; Sergio Chacim; Isabel Ferreira; Luis Leite; Claudia Moreira; Dulcineia Pereira; Margarida Dantas; Marta Nunes; Luisa Viterbo; Ilidia Moreira; Angelo Martins; Isabel Oliveira; Nelson Domingues; Jose Mariz; Rui Medeiros
Journal:  Mol Clin Oncol       Date:  2017-01-20

Review 3.  New drugs in acute myeloid leukemia.

Authors:  T M Kadia; F Ravandi; J Cortes; H Kantarjian
Journal:  Ann Oncol       Date:  2016-01-22       Impact factor: 32.976

Review 4.  Management of Newly Diagnosed Acute Myeloid Leukemia in the Elderly: Current Strategies and Future Directions.

Authors:  David Sanford; Farhad Ravandi
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

5.  Intensive care unit outcomes in patients with hematological malignancy.

Authors:  Jarrod Leigh Rawson; Fionnuala Mary Fagan; Georgin Claire Burrough; Helen Michelle Tang; Moire Alys Cuncannon; Katrina Louise Ellem; Anoop Kumar Enjeti
Journal:  Blood Sci       Date:  2020-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.